icone plus
Contact
Abonnez-vous aux actualités
Nature de la demande
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
87zN2VLKhynpPavX